Free Shipping on orders over $200!
Logo Loading
cause of inflammation in the body

Cannabigerol (CBG) is a non-psychoactive cannabinoid that is found in the cannabis plant. CBG is often referred to as the “mother” of all cannabinoids because it is the precursor to THC, CBD, and other cannabinoids. CBG is known to have various therapeutic properties, including anti-inflammatory, anti-tumor, and neuroprotective effects.

So, how can you use CBG?

CBG can be used in various forms, including oils, capsules, and topicals. The most common way to use CBG is through oil or tincture. CBG oil can be ingested orally or applied topically. The dosage of CBG oil will depend on the individual’s medical condition and the severity of their symptoms. It is recommended to start with a low dose and gradually increase it until the desired effects are achieved.

CBG capsules are another way to consume CBG. They can be ingested orally and have a pre-measured dosage. CBG capsules are a convenient way to use CBG, especially for those who do not like the taste of the oil.

CBG topicals are used for localized pain and inflammation. They can be applied directly to the affected area, and the effects are usually felt within a few minutes. CBG topicals can be found in various forms, including creams, balms, and lotions.

In conclusion, CBG is a versatile cannabinoid that can be used to treat a range of medical conditions. It can be consumed in various forms, including oils, capsules, and topicals. The dosage of CBG will depend on the individual’s medical condition and the severity of their symptoms.  It is recommended to consult a healthcare professional before using CBG for medical purposes.

References 

Gowran, A., & Noonan, J. (2020). Cannabigerol and Its Therapeutic Potential. In Handbook of Cannabis and Related Pathologies (pp. 301-311). Academic Press.

Navarro, G., Varani, K., & Guzmán, M. (2020). Therapeutic Potential of CBG in Neurological and Neuropsychiatric Disorders. In Handbook of Cannabis and Related Pathologies (pp. 285-300). Academic Press.

Pisanti, S., Bifulco, M., & Cascio, M. G. (2020). Cannabigerol: A Potential New Hope for the Treatment of Neuroinflammation and Neurodegenerative Diseases. In Handbook of Cannabis and Related Pathologies (pp. 313-322). Academic Press.




author avatar
Josh Maixner

3 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *